<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> is caused by expansion of a hematopoietic stem cell clone with an acquired <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> in the PIG-A gene </plain></SENT>
<SENT sid="1" pm="."><plain>This mutation aborts the synthesis and expression of the <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi> anchor proteins CD55 and CD59 on the surface of blood cells, thereby making them more susceptible to complement-mediated damage </plain></SENT>
<SENT sid="2" pm="."><plain>A spectrum of disorders occurs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> ranging from <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> to <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and, myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is one of the most serious and life-threatening complications of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>, and a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone is found in almost a third of the cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>While allogeneic bone marrow transplantation and T cell immune suppression are effective treatments for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>, these therapies have significant limitations </plain></SENT>
<SENT sid="5" pm="."><plain>We report here the first case, to our knowledge, of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> associated with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> treated with the anti-CD20 monoclonal antibody rituximab, which was associated with a significant reduction in the size of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone and recovery of hematopoiesis </plain></SENT>
<SENT sid="6" pm="."><plain>We suggest that this less toxic therapy may have a significant role to play in treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> associated with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>